AZURECELL
LIVE

Serial Number

79448144

Owner

AZURECELL SA

Attorney

Andrea L. Hintz

Filing Date

Jan 14, 2026

Add to watchlist:

No watchlists yet
View on USPTO

AZURECELL Trademark

Serial Number: 79448144

AZURECELL is a trademark filed by AZURECELL SA on January 14, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

AZURECELL SA

Avenue de la Roseraie 64

Entity Type: 98

Trademark Details

Filing Date

January 14, 2026

Registration Date

Not Registered

Published for Opposition

September 8, 2026

Goods & Services

Biological preparations for use in cell cultures, other than for medical or veterinary use; stem cells other than for medical or veterinary use; cells other than for medical or veterinary use; cell culture reagents for scientific and research use; biological preparations, namely, fluid matrices for use in scientific and medical research; cell culture media other than for medical or veterinary use; biological preparations, namely, cell lines for scientific use; molecular genetics reagents, plasmids being small independently replicating pieces of DNA, and vectors being small independently replicating pieces of DNA that can transfer DNA sequences, being chemicals for scientific use

Medical services; regenerative medicine services; cultured cell bank services for medical transplantation; medical treatment services by means of cultured cells; medical treatment services by means of stem cell therapy; providing regenerative medicine services for third parties in the form of cell culture services, namely, preparation, expansion and characterization of cells to be used for therapeutic purposes; providing clinical advice on cell therapy; genetic analysis services for medical use

Pharmaceutical products for the treatment of neurodegenerative disorders; diagnostic preparations for medical and veterinary use; pharmaceutical preparations for activating cellular functions; medical preparations for the treatment of the brain and nervous system, namely, neurodegenerative diseases and movement disorders; medical preparations for the treatment of Parkinson's disease; biotechnological preparations for medical use, namely, stem cell-derived cellular preparations for the treatment of neurological disorders and genetically engineered cellular preparations for the treatment of neurological disorders; biotechnological preparations for medical use, namely, gene or cell therapy; cells for medical use; living cells and living biological tissue cultures for medical use; theranostic therapeutic cells for medical purposes; surgical implants comprised of living tissues and cells; chemical or biological reagents and cell culture media for medical use; diagnostic agents for medical use; diagnostic kits comprising diagnostic agents, preparations and substances for medical use

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 8, 2026 NPUB
PUBLISHED FOR OPPOSITION
Sep 8, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Sep 3, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 2, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 19, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 19, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 10, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 10, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Aug 10, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Aug 10, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 10, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 30, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 30, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 30, 2026 TROA
REFUSAL PROCESSED BY IB
Jul 23, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 7, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jul 7, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 20, 2026 RFCR
NON-FINAL ACTION WRITTEN
May 19, 2026 CNRT
ASSIGNED TO EXAMINER
May 12, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 22, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 16, 2026 REPR